Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious Phenotype

被引:1
作者
Costagliola, Giorgio [1 ]
Legitimo, Annalisa [2 ]
Bertini, Veronica [3 ]
Alberio, Antonino Maria Quintilio [4 ]
Valetto, Angelo [3 ]
Consolini, Rita [2 ]
Grammatikos, Alexandros
机构
[1] Azienda Osped Univ Pisana, Sect Pediat Hematol & Oncol, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Pediat Unit, Sect Clin & Lab Immunol, I-56126 Pisa, Italy
[3] Azienda Osped Univ Pisana, Dept Lab Med, Sect Cytogenet, I-56126 Pisa, Italy
[4] Univ Pisa, Dept Clin & Expt Med, Pediat Unit, I-56126 Pisa, Italy
关键词
autoimmunity; dendritic cells; immune dysregulation; infections; memory T cells; naive T cells; recent thymic emigrants; DENDRITIC CELLS; AUTOIMMUNITY; DEFICIENCY; COHORT;
D O I
10.3390/jcm12247579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical expression of 22q11.2 deletion syndrome (22q11.2 DS) is extremely variable, as patients can present with recurrent or severe infections, immune dysregulation, atopic diseases, or extra-immunological manifestations. The immunological background underlying the different disease manifestations is not completely elucidated. The aim of this study was to identify the immunophenotypic peculiarities of 22q11.2 DS patients presenting with different disease expressions. This study included 34 patients with 22q11.2 DS, divided into three groups according to the clinical phenotype: isolated extra-immunological manifestations (G1), infectious phenotype with increased/severe infections (G2), and immune dysregulation (G3). The patients underwent extended immunophenotyping of the T and B lymphocytes and analysis of the circulating dendritic cells (DCs). In patients with an infectious phenotype, a significant reduction in CD3+ and CD4+ cells and an expansion of CD8 naive cells was evidenced. On the other hand, the immunophenotype of the patients with immune dysregulation showed a skewing toward memory T cell populations, and reduced levels of recent thymic emigrants (RTEs), while the highest levels of RTEs were detected in the patients with isolated extra-immunological manifestations. This study integrates the current literature, contributing to elucidating the variability in the immune status of patients with 22q11.2DS with different phenotypic expressions, particularly in those with infectious phenotype and immune dysregulation.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] 22q11.2 Deletion Syndrome in Taiwan: Clinical Presentation and Immune System Status of Patients
    Lee, Chung-Lin
    Lin, Shan-Miao
    Chen, Ming-Ren
    Chuang, Chih-Kuang
    Chiu, Huei-Ching
    Tu, Yuan-Rong
    Lo, Yun-Ting
    Chang, Ya-Hui
    Lin, Hsiang-Yu
    Lin, Shuan-Pei
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (11): : 1377 - 1385
  • [22] Vaccine immunity in patients with 22q11.2 microdeletion syndrome
    Farpour, Leila
    Gualtieri, Renato
    Kotalova, Tereza
    Lemaitre, Barbara
    Ducreux, Julie
    Arm-Vernez, Isabelle
    Eliez, Stephan
    Blanchard-Rohner, Geraldine
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2025, 36 (02)
  • [23] DiGeorge Syndrome/Velocardiofacial syndrome: The chromosome 22q11.2 deletion syndrome
    Sullivan, Kathleen E.
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 37 - 49
  • [24] Clinical Phenotype, Immunological Abnormalities, and Genomic Findings in Patients with DiGeorge Spectrum Phenotype without 22q11.2 Deletion
    Cirillo, Emilia
    Prencipe, Maria Rosaria
    Giardino, Giuliana
    Romano, Roberta
    Scalia, Giulia
    Genesio, Rita
    Nitsch, Lucio
    Pignata, Claudio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09) : 3112 - 3120
  • [25] Lymphoproliferative disorder with polyautoimmunity and hypogammaglobulinemia: An unusual presentation of 22q11.2 deletion syndrome
    Soares, Diogo C.
    Dantas, Anelisa G.
    Matta, Marina C.
    Pastorino, Antonio C.
    Melaragno, Maria Isabel
    Kulikowski, Leslie
    Montenegro, Marilia
    Kim, Chong A.
    Carneiro-Sampaio, Magda
    Torres, Leuridan C.
    CLINICAL IMMUNOLOGY, 2020, 220
  • [26] Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
    Zemble, R.
    Prak, E. Luning
    McDonald, K.
    McDonald-McGinn, D.
    Zackai, E.
    Sullivan, K.
    CLINICAL IMMUNOLOGY, 2010, 136 (03) : 409 - 418
  • [27] Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome
    Borna, Simon
    Dejene, Beruh
    Lakshmanan, Uma
    Schulze, Janika
    Weinberg, Kenneth
    Bacchetta, Rosa
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Inherited or Immunological Thrombocytopenia: The Complex Nature of Platelet Disorders in 22q11.2 Deletion Syndrome
    Urbanski, Bartosz
    Urbanski, Zuzanna
    Babol-Pokora, Katarzyna
    Subocz, Ewelina
    Mlynarsk, Wojciech
    Janczar, Szymon
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2025,
  • [29] Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits
    Mekori-Domachevsky, Ehud
    Taler, Michal
    Shoenfeld, Yehuda
    Gurevich, Michael
    Sonis, Polina
    Weisman, Omri
    Weizman, Abraham
    Gothelf, Doron
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (09) : E1219 - E1225
  • [30] Systems biology reveals biomarkers and pathways involved in autoimmunity in 22q11.2 deletion syndrome
    Baloh, Carolyn
    Venturi, Guglielmo
    Fischer, Bernard
    Sleasman, John
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S117 - S117